An in vitro cytotoxic assay using mesothelin-expressing K562 cells revealed that CD4+CD26high T cells have a similar, if not enhanced, capacity to kill cancer compared to CD8+ cells (Supplementary Fig. 6g). This evidence concerns the gene CD4 and cancer.